Cardiovascular Diseases Clinical Trial
Official title:
Evaluating the Impact of Singing Interventions on Markers of Cardiovascular Health in Older Patients With Cardiovascular Disease
Verified date | May 2024 |
Source | Medical College of Wisconsin |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cardiovascular disease (CVD) claims more lives each year than cancer and chronic respiratory disease combined. Participation in cardiac rehabilitation (CR) reduces mortality and risk of a major cardiovascular event in secondary prevention populations, including older adults. Older adults are less likely to participate in CR, as comorbidities in this population, including arthritis and chronic obstructive pulmonary disease, make participation difficult. Singing is a physical activity that involves components of the vagal nerves manifested as changes in cardiac autonomic regulation. Unlike physical exercise, the effects of singing on cardiovascular health has not been well-studied. The hypothesis for this project is that older patients with CVD will have favorable improvement in cardiovascular biomarkers, including, endothelial function and heart rate variability (HRV), after 30 minutes of singing.
Status | Active, not recruiting |
Enrollment | 65 |
Est. completion date | September 30, 2024 |
Est. primary completion date | August 18, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 55 Years to 79 Years |
Eligibility | Inclusion Criteria: - English Speaking - Have a history of coronary artery disease (defined as history of myocardial infarction, coronary stenosis >50%, percutaneous coronary intervention with stent placement, balloon angioplasty, or coronary arterial bypass grafting) Exclusion Criteria: - Subjects with a permanent pacemaker or implantable cardioverter defibrillator (ICD) implanted - Patients with a history of atrial fibrillation, flutter or atrial tachycardia - Parkinson's disease or a tremor - Amputated upper extremity or presence of upper-arm (dialysis) fistula - Fingernail onychomycosis (fungal infections resulting in thickening of the nails) - Pregnancy - Current illicit drug use (marijuana, tobacco, cocaine, amphetamines, etc.) - Current excessive alcohol use (defined as more than 14 drinks/week for women, more than 28 drinks/week for men) - Unstable coronary heart disease (active symptoms of chest discomfort) - History of a Stroke or TIA or peripheral arterial disease - Known history of cognitive impairment or inability to follow study procedures - Cancer requiring systemic treatment within five years of enrollment. - Subjects requiring supplemental oxygen use - Non-English speaking subjects (video with lyrics are taped in English) |
Country | Name | City | State |
---|---|---|---|
United States | Medical College of Wisconsin | Milwaukee | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
Medical College of Wisconsin |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | the change in TNF-alpha, IL-1 Beta, IL-6, and IL-8 | measure the change in TNF-alpha, IL-1 Beta, IL-6, and IL-8 | at baseline and 30 minutes later (after interventions or sham) | |
Other | Visual Mood Score | Arts Observation Scale to evaluate the effect of performing arts activities in healthcare settings. Two reactions (relaxation and distraction) will be scored by the research coordinator nurse based on direct observation of the subjects during the singing intervention. The qualitative portion of this instrument enables the collection of personal feedback and quotations from subjects. Observers (research team) can also gather more detailed accounts of subjects' responses to activities, including experience and perceptions | at baseline and 30 minutes later (after interventions or sham) | |
Primary | change in vascular (endothelial) function | Measure endothelial function and brachial artery flow-mediated dilation | At baseline and after 30-minute singing and sham intervention(s) | |
Primary | change in vascular (endothelial) function | Measure endothelial function (reactive hyperemia index, and PAT ratio) through finger plethysmography using EndoPAT | At baseline and after 30-minute singing and sham intervention(s) | |
Secondary | level of exertion achieved during singing | BORG Rating of Perceived Exertion | after 30-minute singing (and sham) interventions | |
Secondary | level of exertion achieved during singing | percent of maximum predicted heart rate achieved | after 30-minute singing (and sham) interventions | |
Secondary | cardiac hemodynamics | heart rate variability will be measured before, during and post singing | at baseline and after 30-minute singing and sham intervention(s) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|